Sun Pharma Expands Sterile Injectable Capacity with Acquisition of Pharmalucence

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Pharmalucence Inc., by one of its subsidiaries. Pharmalucence, a privately held company based in Billerica, Massachusetts, has sterile injectable capacity supported by R&D capabilities.

Pharmalucence has a new 70,000-square foot manufacturing facility in Billerica for automated, isolated aseptic filling. Pharmalucence expects to begin drug manufacturing at the site in the early fourth quarter of 2014.

Source: Sun Pharmaceutical and Pharmalucence

Leave a Reply

Your email address will not be published. Required fields are marked *